Profile
BDXA ISRG BDX ALC RMD BAX
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. Baxter International Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $64.58B $176.09B $65.60B $45.56B $33.16B $17.66B
Employees 0.00K 15.64K 70.00K 25.60K 9.98K 38.00K
CEO - Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. David Brent Shafer
Ratings
BDXA ISRG BDX ALC RMD BAX
Quant Rating Score 5 3 3 3 3 1
Quant Rating Strong Buy Neutral Neutral Neutral Neutral Strong Sell
Trading
BDXA ISRG BDX ALC RMD BAX
Last Close $59.24 $493.72 $224.92 $89.15 $225.79 $35.85
High 52 $59.24 $610.45 $249.08 $100.76 $257.65 $43.55
Low 52 $59.24 $366.34 $220.02 $77.58 $173.83 $28.63
Price vs. 52 Week High 0 % -19.12 % -9.7 % -11.52 % -12.37 % -17.68 %
Price vs. 52 Week Low 0 % 34.77 % 2.23 % 14.91 % 29.89 % 25.22 %
Total Return
BDXA ISRG BDX ALC RMD BAX
1 Month Return 0 % -16.26 % -0.41 % 1.12 % -4.57 % 18.36 %
3 Month Return 0 % -8.5 % -0.28 % 5.92 % -5.34 % 18.24 %
6 Month Return 0 % -0.06 % -4.49 % -11.52 % -9.94 % -8.96 %
9 Month Return 0 % 15.33 % -3.88 % -3.37 % 7.07 % 7.63 %
YTD Return 0 % -5.41 % -0.86 % 5.02 % -1.27 % 22.94 %
1 Year Return 0 % 26.79 % -5.42 % 1.16 % 16.52 % -16.41 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXA ISRG BDX ALC RMD BAX
Dividend Yield Percentage (TTM) 1.73 % - 1.7 % 0.29 % 0.92 % 2.67 %
Dividend Paid and Capex Coverage Ration (TTM) 1.98 % 2.17 % 1.98 % 2.05 % 3.84 % 0.98 %
Dividend Per Share (TTM) 3.89 % - 3.89 % 0.26 % 2.07 % 0.92 %
Payout Ratio (TTM) 65.26 % - 65.26 % 13.01 % 23.76 % -90.91 %
Growth
BDXA ISRG BDX ALC RMD BAX
Asset Growth 8.54 % 8.54 % -8.82 %
Gross Profit Growth 11.69 % 11.69 % -65.81 %
Revenue Growth 4.16 % 4.16 % -69.53 %
Revenue 3 Year -0.51 % -0.51 % -65.25 %
Revenue 5 Year 8.72 % 8.72 % -60.36 %
Revenue 10 Year 59.37 % 59.37 % -71.23 %
EBIT Growth 13.55 % 13.55 % -128.72 %
Net Income Growth 14.89 % 14.89 % -111.75 %
Net Income 3 Yeari Growth Per Share -18.63 % -18.63 % -123.92 %
Net Income 5 Yeari Growth Per Share 30.19 % 30.19 % -131.11 %
Net Income 10 Yeari Growth Per Share -4.02 % -4.02 % -113.28 %
Operating Income Growth 13.55 % 13.55 % -128.72 %
Operating Cash Flow Growth (CFG) 28.6 % 28.6 % -40.96 %
Operating 3 Year CFG -17.42 % -17.42 % -54.86 %
Operating 5 Year CFG 7.54 % 7.54 % -51.66 %
Operating 10 Year CFG 47.04 % 47.04 % -66.32 %
EPS Growth 18.31 % 18.31 % -111.62 %
EPS Diluted Growth 18.62 % 18.62 % -111.62 %
Book Value Per Share -0.85 % -0.85 % -17.7 %
Share Holder 3 Year Equity Growth Per Share 9.26 % 9.26 % -24.48 %
Share Holder 5 Year Equity Growth Per Share 13.99 % 13.99 % -11.82 %
Share Holder 10 Year Equity Growth Per Share 242.08 % 242.08 % -8.86 %
Dividend Per Share Growth -2.44 % -2.44 % -0.11 %
Dividend 3 Year Growth Per Share 4.79 % 4.79 % 9.57 %
Dividend 5 Year Growth Per Share 4.14 % 4.14 % 39.21 %
Dividend 10 Year Growth Per Share 74.3 % 74.3 % -42.74 %
Debt Growth 26.65 % 26.65 % -6.93 %
Free Cash Flow Growth 47.47 % 47.47 % -45.94 %
Updated On 30 Sep 2024 30 Sep 2024 31 Dec 2024
Profitability
BDXA ISRG BDX ALC RMD BAX
Gross Profit Margin TTM 45.22 % 67.46 % 45.22 % 55.61 % 57.94 % 37.11 %
Return on Assets TTM 3.16 % 12.39 % 3.16 % 3.35 % 17.49 % -2.52 %
Return on Equity TTM 6.73 % 15.31 % 6.73 % 6.43 % 25.05 % -8.47 %
Return on Capital Employed TTM 5.64 % 13.82 % 5.64 % 5.03 % 24.81 % -0.73 %
Net Income Per EBT TTM 88.43 % 86.87 % 88.43 % 81.05 % 81.35 % 109.44 %
EBT Per Ebit TTM 73.61 % 113.83 % 73.61 % 88.89 % 98.37 % 423.57 %
EBIT Per Revenue TTM 12.85 % 28.12 % 12.85 % 14.24 % 31.67 % -1.09 %
Cash Flow To Debt Ratio TTM 19.46 % - 19.46 % 36.06 % 175.81 % 7.58 %
Receivables Turnover TTM 7.82 6.16 7.82 4.77 5.73 7.43
Payables Turnover TTM - 14.05 - 5.7 9.41 8.35
Inventory Turnover TTM 2.93 1.83 2.93 1.94 2.35 3.95
Fixed Asset Turnover TTM 312.63 % 179.75 % 312.63 % 205.17 % 734.05 % 404.79 %
Asset Turnover TTM 37.76 % 44.56 % 37.76 % 32.71 % 68.99 % 49.86 %
Operating Cash Flow Per Share TTM 12.61 6.78 12.61 3.75 10.05 2
Free Cash Flow Per Share TTM 10.14 3.66 10.14 2.19 9.45 1.11
Cash Per Share TTM 251.46 % 1126.07 % 251.46 % 370.15 % 355.4 % 345.88 %
Operating Cash Flow Sales Ratio TTM 17.68 % 28.91 % 17.68 % 18.66 % 29.96 % 7.93 %
Free Cash Flow Operating Cash Flow Ratio TTM 80.44 % 53.99 % 80.44 % 58.38 % 94.04 % 55.54 %
Cash Flow Coverage Ratios TTM 19.46 % - 19.46 % 36.06 % 175.81 % 7.58 %
Price To Free Cash Flows Ratio TTM 22.04 135.06 22.34 42.14 23.88 31.19
Price To Operating Cash Flows Ratio TTM 17.87 72.86 18.12 24.59 22.46 17.27
Price Cash Flow Ratio TTM 17.87 72.86 18.12 24.59 22.46 17.27
Income Statement (TTM)
BDXA ISRG BDX ALC RMD BAX
Revenue $20.18B $8.35B $20.18B $9.91B $4.69B $4.51B
Gross Profit $9.13B $5.63B $9.13B $5.51B $2.66B $1.7B
Gross Profit Ratio 45.22% 67.5% 45.22% 55.61% 56.67% 37.69%
EBITDA $4.85B $2.67B $4.85B $2.68B $1.53B $-0.11B
Net Income $1.71B $2.32B $1.71B $1.02B $1.02B $-0.31B
EPS Diluted 5.86 6.42 5.86 2.05 6.92 -0.61
Balance Sheet (MRQ)
BDXA ISRG BDX ALC RMD BAX
Long Term Debt $17.94B $0B $17.94B $4.97B $0.84B $10.62B
Total Liabilities $31.4B $2.21B $31.4B $8.79B $2.01B $18.76B
Total Equity $25.91B $16.53B $25.91B $21.55B $4.86B $7.02B
Total Investments $0.45B $6.81B $0.45B $0.75B $0.17B $0.11B
Total Debt $20.11B $0B $20.11B $5.14B $0.87B $13.37B
Total Assets $57.29B $18.74B $57.29B $30.35B $6.87B $25.78B
Cash Flow Statement (TTM)
BDXA ISRG BDX ALC RMD BAX
Net Income $1.71B $2.34B $1.71B $1.02B $1.02B $-0.33B
Inventory $0.1B $-0.83B $0.1B $-0.05B $0.17B $-0.2B
Dividends Paid $-1.1B $0B $-1.1B $-0.13B $-0.28B $-0.59B
Operating Cash Flow $3.84B $2.42B $3.84B $2.08B $1.4B $1.02B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.67B $-0.11B $-0.45B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.62
ALC Alcon Inc. 89.22
ANGO AngioDynamics, Inc. 9.05
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 147.715
ATRC AtriCure, Inc. 33.39
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 38.79
BAX Baxter International Inc. 35.08
BDX Becton, Dickinson and Company 225.97
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.405
BLFS BioLife Solutions, Inc. 26.41
COO The Cooper Companies, Inc. 80.51
DXR Daxor Corporation 7.9
EKSO Ekso Bionics Holdings, Inc. 0.3891
FEMY Femasys Inc. 1.49
GCTK GlucoTrack, Inc. 0.3564
Unlock